We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics UK Ltd.

Download Mobile App




Sensor Detects Lactate Levels in Individual Cancer Cells

By LabMedica International staff writers
Posted on 25 Mar 2013
Print article
A team of scientists devised a molecular sensor that detects levels of lactate in individual cells. A high rate of lactate production indicates that cancer is present, via diagnostics such as positron emission tomography (PET) scans, and may offer an opportunity for novel cancer therapies.

The scientists used a bacterial transcription factor—a protein that binds to specific DNA sequences to control the flow of genetic information from DNA to mRNA—as a means to produce and insert the lactate sensor. They turned on the sensor in three cell types: normal brain cells, tumor brain cells, and human embryonic cells. The sensor was able to quantify very low concentrations of lactate, providing good sensitivity and range of detection. Sugars are broken up by cancer cells and produce the metabolic acid lactate at a much greater rate than normal cells. The tumor cells produced lactate three to five times faster than the nontumor cells.

“The high rate of lactate production in the cancer cell is the hallmark of cancer metabolism,” remarked Prof. Frommer. “This result paves the way for understanding the nuances of cancer metabolism in different types of cancer and for developing new techniques for combating this scourge.”

Chilean researchers from the Centro de Estudios Científicos (CECs; Valdivia, Chile) with the collaboration of Carnegie’s Institute of Washington (Washington DC, USA) Prof. Wolf Frommer devised the molecular sensor that detects levels of lactate in individual cells. Prior to this advance, no other measurement method could noninvasively detect lactate in real time at the single-cell level. The work, published in the February 26, 2013, edition of the open access journal PLOS ONE, is a boon to understanding how different types of cells go awry when cancer hits.

The biosensors also might be able to solve an old controversy. While some studies have suggested the glucose provides fuel for the brain, recent research has provided evidence that lactate feeds energy metabolism in neurons. Oxidation of lactate can be used to produce large amounts of adenosine tri-phosphate (ATP), the coenzyme that carries energy in cells. The Barros and Frommer teams are excited about the possibility of solving this enigma with the use of their new sensors, together with previously developed glucose sensors.

“Over the last decade, the [Wolf] Frommer lab at Carnegie’s Institution of has pioneered the use of Förster resonance energy transfer, or FRET, sensors to measure the concentration and flow of sugars in individual cells with a simple fluorescent color change. This has started to revolutionize the field of cell metabolism,” explained CECs researcher Alejandro San Martin, lead author of the article. “Using the same underlying physical principle and inspired by the sugar sensors, we have now invented a new type of sensor based on a transcriptional factor. A molecule that normally helps bacteria to adapt to its environment has now been tricked into measuring lactate for us.”

Related Links:
Centro de Estudios Científicos
Carnegie’s Institute of Washington

New
Gold Member
Blood Gas Analyzer
GEM Premier 7000 with iQM3
Unit-Dose Packaging solution
HLX
New
Human Papillomavirus Multiplex Assay
Anyplex Ⅱ HPV28 Detection
New
Dengue Test
Lab Rapid Dengue NS1

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.